Why Crinetics Pharmaceuticals Shares Are Trading Higher By 99%; Here Are 20 Stocks Moving PremarketBenzinga • 07/07/26
Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?The Motley Fool • 07/06/26
While SpaceX Gets the Headlines, Smart Investors Are Loading Up on This Stock InsteadThe Motley Fool • 07/05/26
Wall Street Bulls Look Optimistic About Vertex (VRTX): Should You Buy?Zacks Investment Research • 07/03/26
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?The Motley Fool • 07/03/26
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta ThalassemiaBusiness Wire • 07/01/26
US FDA approves Vertex's gene therapy for sickle cell disease in children as young as twoReuters • 07/01/26
Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?The Motley Fool • 07/01/26
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In BiotechSeeking Alpha • 06/30/26
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 06/27/26
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained TodayZacks Investment Research • 06/26/26
Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade)Seeking Alpha • 06/24/26
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.The Motley Fool • 06/20/26
The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex24/7 Wall Street • 06/12/26